Alterity Therapeutics Limited (ATHE) - Cash on Hand per Share

Alterity Therapeutics Limited - graphic logo of issuer ATHE

The cash per share metric reflects the impact of stringent FDA oversight and high development costs, with 1.34 becoming the new value for this indicator. Alterity Therapeutics (ATHE) focuses on therapies for rare brain pathologies to save neurons. However, geopolitical instability and logistics disruptions in sanctioned regions create financial risks for conducting global trials.

Alterity Therapeutics Ltd (ATHE) - Cash per Share from 07/04/2022 to 11/20/2026

Comprehensive metric breakdowns and analytics for Alterity Therapeutics Ltd. (ATHE)

- cash availability and cash flow indicators:
General company analysis:ATHE, Alterity Therapeutics Ltd
Manufactured products of Alterity Therapeutics Limited

Cash per share is of key importance for assessing the financial stability of Alterity Therapeutics (ATHE). This indicator determines the portion of liquid assets attributable to a single security. The current value of 1.34 reflects the actual capital reserve available to support operational activities. For a biotech company without revenue, this calculation measures the cash burn rate for R&D projects. A steady decline in this metric signals the approaching need for recapitalization.

Competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|CLNN: Cash per Share|Cash per Single Share PepGen Inc.|JUNS (Jupiter Neurosciences, Inc.) - Cash per Share|Cash on Hand per Share Relmada Therapeutics Inc RLMD|Cash Funds per Share Annovis Bio Corporation (ANVS)|GRCE - Cash on Hand per Share|Cash Funds per Share Firefly Neuroscience, Inc. AIFF|Klotho Neurosciences Inc (KLTO) - Cash on Hand per Share|NeuroSense Therapeutics, Ltd. - Cash per Share|RVPH: Cash Funds per Share|MTVA: Cash per Share|NRXS - Cash Funds Calculated per Share|HSDT (Helius Medical Technologies Inc.) - Cash per Share|Cash on Hand per Share Passage Bio PASG|Cash Funds per Share Neuphoria (NEUP)|Cash per Share Minerva Neurosciences Corp (NERV)|Cash Funds per Share Athira ATHA|Cash per Share Addex ADXN|Alzamend - Cash per Share|Cash on Hand per Share Cyclerion Therapeutics, Inc.|Protagenic Therapeutics (PTIX) - Cash Funds per Share|KTTA: Cash Calculated per Single Share|Cash per Single Share CRGT|Avenue Therapeutics, Inc - Cash Money per Share|Cash Funds per Share Brainstorm Cell (BCLI)|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share